CMS Input On Pivotal Trials Could Anticipate Medicare Coverage Issues – Brooks-LaSure

 
• By Cathy Kelly
  
CMS tries to educate Congress on Medicare coverage policy as its final Alzheimer's drug decision approaches. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Government Payers